ARCHIVES

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

NCI Contract Awards

November 1, 1996

Applications Due Sept. 1 For Cancer Prevention Fellows

May 10, 1991

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009